E-LIB Suche - Ergebnisse für: Dupuis, Robert E.

1

Alemtuzumab in Renal Retransplantation – Transplant Outcome..:

Harris, Taylor N. ; Szempruch, Kristen R. ; Dupuis, Robert E...
Transplantation Proceedings. 53 (2021) 10 - p. 2888-2894 , 2021

Link: https://doi.org/10.1016/..

2

Emerging Subspecialties in Neurology: Clinical development:

Guptill, Jeffrey T. ; Dupuis, Robert E. ; D'Cruz, O'Neill
Neurology. 80 (2013) 1 - p. , 2013

Link: https://doi.org/10.1212/..

3

Pursuing a career in transplant pharmacy:

Eisenhart, Alison ; Dupuis, Robert E.
American Journal of Health-System Pharmacy. 65 (2008) 24 - p. 2331-2333 , 2008

Link: https://doi.org/10.2146/..

4

The Influence of Norfloxacin and Metronidazole on the Dispo..:

Naderer, Odin J. ; Dupuis, Robert E. ; Heinzen, Erin L....
The Journal of Clinical Pharmacology. 45 (2005) 2 - p. 219-226 , 2005

Link: https://doi.org/10.1177/..

5

Evaluation of Estimated and Measured Creatinine Clearances ..:

Taber, David J. ; Fann, Amy L. ; Malat, Greg.
Therapeutic Drug Monitoring. 25 (2003) 1 - p. 67-72 , 2003

Link: https://doi.org/10.1097/..

6

Assessment of Risk Factors for Bone Disease in Renal Transp..:

Joy, Melanie S ; Hollar, Kimberly D ; Neyhart, Clara D...
Journal of Pharmacy Technology. 18 (2002) 2 - p. 54-62 , 2002

Link: https://doi.org/10.1177/..

7

Medical Management Considerations for Patients With Lung Tr..:

Dupuis, Robert E. ; Taber, David J. ; Fann, Amy L..
Journal of Pharmacy Practice. 14 (2001) 4 - p. 258-276 , 2001

Link: https://doi.org/10.1106/..

8

COMPARISON OF CMV PROPHYLAXIS AND PREEMPTIVE THERAPY IN LIV..:

Taber, David J. ; Dupuis, Robert E. ; Hollar, Kimberly D....
Transplantation. 69 (2000) Supplement - p. S181 , 2000

Link: https://doi.org/10.1097/..

9

PREVALENCE OF LOW BONE MASS AND RISK FACTORS IN PATIENTS AW..:

Hollar, Kimberly D. ; Zacks, Steven L. ; Dupuis, Robert E....
Transplantation. 69 (2000) Supplement - p. S316 , 2000

Link: https://doi.org/10.1097/..

10

Tobramycin Pharmacokinetics in Patients with Cystic Fibrosi..:

Dupuis, Robert E. ; Sredzienski, Edward S.
Therapeutic Drug Monitoring. 21 (1999) 2 - p. 161-165 , 1999

Link: https://doi.org/10.1097/..

11

Risk Factors for Steroid Induced Bone Disease in Renal Tran..:

Joy, Melanie S. ; Hollar, Kimberly D. ; Neyhart, Clara D....
Transplantation. 65 (1998) 12 - p. S74 , 1998

Link: https://doi.org/10.1097/..

12

Risk Factors for Steroid Induced Bone Disease in Renal Tran..:

Joy, Melanie S. ; Hollar, Kimberly D. ; Neyhart, Clara D....
Transplantation. 65 (1998) Supplement - p. 150 , 1998

Link: https://doi.org/10.1097/..

13

Vancomycin Serum Concentrations in Patients with Renal Dysf..:

Peckman, Howard J. ; Dupuis, Robert E. ; Sawyer, William T...
Therapeutic Drug Monitoring. 18 (1996) 6 - p. 647-653 , 1996

Link: https://doi.org/10.1097/..

14

Salivary Theophylline Monitoring: Reassessment and Clinical..:

Kirk, Julienne K. ; Dupuis, Robert E. ; Miles, Michael V....
Therapeutic Drug Monitoring. 16 (1994) 1 - p. 58-66 , 1994

Link: https://doi.org/10.1097/..

15

Single- and multiple-dose pharmacokinetics of a low-dose or..:

Price, Thomas M. ; Dupuis, Robert E. ; Carr, Bruce R....
American Journal of Obstetrics and Gynecology. 168 (1993) 5 - p. 1400-1406 , 1993

Link: https://doi.org/10.1016/..